Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h

Google maps

Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :

BHIVA: Saving lives saves money: preventing mother-to-child HIV infection saves NHS £3.1 billion

Experts call for continued focus on the impact of HIV on women and babies London, UK – 27 November 2015 More than 5,000 babies across the UK have avoided being born with HIV in the last 15 years, because of the care received by their mothers before, during and after childbirth, according to figures announced today by the British HIV Association (BHIVA). About 15,000...


Source Source: BHIVA

Dutch research identifies relationship between HIV clinic characteristics and retention of patients in care

Dutch research published in the online edition of AIDS has provided insights into the relationship between the characteristics of HIV clinics and the retention of patients in care. All 26 specialist HIV care providers in the Netherlands had good rates of retention in care, but a number of characteristics were associated with the likelihood of patients starting treatment and...


Source Source: Aidsmap

UNICEF: steep rise in adolescent AIDS-related deaths in past 15 years

Every hour across the globe, 26 adolescents aged 15 to 19 become infected with HIV. Deaths from AIDS-related illnesses among adolescents have tripled since 2000, says the United Nations Children's Fund (UNICEF) in data in a report released on 27 November. The report, Statistical update on children, adolescents and AIDS , paints an alarming picture for young people. AIDS-related...


Source Source: UNAIDS

UNITAID reviews landscape in diagnostics technology for HIV

Geneva, 27 November 2015: UNITAID today released its 2015 HIV/AIDS Diagnostics Technology Landscape that summarizes the latest products and technologies to detect, stage and monitor HIV infection. The Landscape covers technologies including instruments for laboratories, multi-purpose platforms and innovations at points of care to diagnose infants and to monitor viral load and CD4....


Source Source: UNITAID

AbbVie's TECHNIVIE™ receives Health Canada approval for genotype 4 chronic hepatitis C infection

TECHNIVIE provides an opportunity to treat adults who have genotype 4 (GT4) chronic hepatitis C virus (HCV) infection without cirrhosis, a population historically considered difficult–to-treat TECHNIVIE is the first and only all-oral, interferon-free, direct-acting antiviral treatment approved in Canada for adult patients with GT4 chronic HCV infection Approval...


Source Source: CNW